Lab Corp Is Recession Resistant
Blood work and other diagnostic tests are rarely thought of as discretionary expenses, especially when most, or all, of the bill is being paid by a third party. Employer-related drug testing certainly is not going to be ignored due to cost.
Industry giant Lab Corp of America (LH) has an enviable track record that is likely to continue regardless of economic conditions. EPS (excluding non-recurring items) grew by 375% from a split-adjusted $1.34 in 2001 to $6.37 in 2011. Sales per share surged 410% over that same decade....247 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.